What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Immune system
Her primary areas of study are Chimeric antigen receptor, Immunology, Antigen, Cytotoxic T cell and Adoptive cell transfer.
Her research integrates issues of T lymphocyte, Interleukin 21, Molecular biology, Genetic enhancement and CD19 in her study of Chimeric antigen receptor.
Her Immunology research is multidisciplinary, incorporating elements of Hematopoietic stem cell transplantation, Transplantation and Cancer research.
Laurence J.N. Cooper has included themes like Signal transduction, Monoclonal antibody and Virology in her Antigen study.
Her Cytotoxic T cell research includes themes of T cell, CD8 and Cell biology.
Within one scientific family, Laurence J.N. Cooper focuses on topics pertaining to T-cell receptor under IL-2 receptor, and may sometimes address concerns connected to Antigen presentation.
Her most cited work include:
- CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells (422 citations)
- Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans. (395 citations)
- A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. (376 citations)
What are the main themes of her work throughout her whole career to date?
Laurence J.N. Cooper mainly focuses on Immunology, Chimeric antigen receptor, Cancer research, Antigen and Immunotherapy.
Her Immunology study combines topics in areas such as Cytotoxic T cell and Transplantation.
Her Cytotoxic T cell study incorporates themes from CD8 and Cell therapy.
Her study in Chimeric antigen receptor is interdisciplinary in nature, drawing from both CD28, Molecular biology, Genetic enhancement, CD19 and Cell biology.
Her Antigen research incorporates elements of Virology, Monoclonal antibody, Genetically modified organism and T-cell receptor.
Her Immunotherapy research integrates issues from Tumor microenvironment and Oncology.
She most often published in these fields:
- Immunology (56.80%)
- Chimeric antigen receptor (44.00%)
- Cancer research (32.80%)
What were the highlights of her more recent work (between 2015-2021)?
- Cancer research (32.80%)
- Immunology (56.80%)
- Immunotherapy (31.20%)
In recent papers she was focusing on the following fields of study:
Laurence J.N. Cooper focuses on Cancer research, Immunology, Immunotherapy, Chimeric antigen receptor and Antigen.
The Cancer research study combines topics in areas such as Natural killer T cell, Cell culture, microRNA and Cytotoxicity.
Her biological study deals with issues like Cytotoxic T cell, which deal with fields such as T cell.
Her Immunotherapy research incorporates themes from Interleukin 12, Genetic enhancement and B cell.
Her Chimeric antigen receptor study combines topics from a wide range of disciplines, such as Transgene, Genetically modified organism, Cytokine-induced killer cell, Receptor and CD19.
Her work in Antigen covers topics such as Computational biology which are related to areas like Cloning, Exome sequencing and Transcriptome.
Between 2015 and 2021, her most popular works were:
- Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (375 citations)
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells (254 citations)
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells (254 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Immune system
Laurence J.N. Cooper mostly deals with Immunology, Chimeric antigen receptor, Immunotherapy, Cancer research and Antigen.
Her Immunology research includes elements of Stem cell, Growth inhibition and Transplantation.
Laurence J.N. Cooper has researched Chimeric antigen receptor in several fields, including Leukemia, Cytokine-induced killer cell and CD19.
As part of her studies on CD19, she often connects relevant subjects like Cytotoxic T cell.
Her Cancer research study integrates concerns from other disciplines, such as Cell growth, Sleeping Beauty transposon system, Cancer immunotherapy, microRNA and T-cell receptor.
The concepts of her Antigen study are interwoven with issues in Tumor necrosis factor alpha, Cancer, T cell, Metastatic breast cancer and Lymph node.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
